We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Buys

Rank Stock Value
1
XYLD icon
Global X S&P 500 Covered Call ETF
XYLD
+$49.5M
2
GXO icon
GXO Logistics
GXO
+$10.2M
3
GSY icon
Invesco Ultra Short Duration ETF
GSY
+$9.29M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$7.06M
5
C icon
Citigroup
C
+$6.92M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WATT icon
1476
Energous
WATT
$77.2M
$33K ﹤0.01%
27
– –
IEAWW
1477
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$30K ﹤0.01%
25,000
– –
NGD
1478
DELISTED
New Gold Inc
NGD
$28K ﹤0.01%
26,946
– –
OTLK icon
1479
Outlook Therapeutics
OTLK
$194M
$28K ﹤0.01%
645
-35
-5% -$1.69K
EGIO
1480
DELISTED
Edgio, Inc. Common Stock
EGIO
$28K ﹤0.01%
293
-37
-11% -$3.9K
WRN
1481
Western Copper and Gold
WRN
$476M
$15K ﹤0.01%
10,000
– –
TXMD icon
1482
TherapeuticsMD
TXMD
$23.5M
$14K ﹤0.01%
383
-382
-50% -$17K
NMTR
1483
DELISTED
9 Meters Biopharma
NMTR
$14K ﹤0.01%
545
– –
DMK
1484
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$12K ﹤0.01%
171
– –
DSKEW
1485
DELISTED
Daseke, Inc. Warrant
DSKEW
$7K ﹤0.01%
34,200
– –
ADC icon
1486
Agree Realty
ADC
$9.42B
– –
-4,700
Closed -$331K
AHT
1487
Ashford Hospitality Trust
AHT
$20.9M
– –
-187
Closed -$85K
APAM icon
1488
Artisan Partners
APAM
$2.82B
– –
-6,787
Closed -$345K
ASHR icon
1489
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
– –
-5,035
Closed -$204K
BCAB icon
1490
BioAtla
BCAB
$5.61M
– –
-117
Closed -$247K
BCRX icon
1491
BioCryst Pharmaceuticals
BCRX
$2.35B
– –
-10,000
Closed -$158K
BEKE icon
1492
KE Holdings
BEKE
$18.8B
– –
-21,819
Closed -$1.04M
BILI icon
1493
Bilibili
BILI
$7.83B
– –
-3,047
Closed -$371K
BLUE
1494
DELISTED
bluebird bio
BLUE
– –
-898
Closed -$372K
BSET icon
1495
Bassett Furniture
BSET
$168M
– –
-22,987
Closed -$560K
BUI icon
1496
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$727M
– –
-8,141
Closed -$210K
CAH icon
1497
Cardinal Health
CAH
$53.2B
– –
-5,638
Closed -$322K
CHGG icon
1498
Chegg
CHGG
$118M
– –
-3,440
Closed -$286K
CMCM
1499
Cheetah Mobile
CMCM
$88.5M
– –
-6,204
Closed -$74K
CMTL icon
1500
Comtech Telecommunications
CMTL
$50.9M
– –
-11,200
Closed -$271K
58 59
60
61 62

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.